Sustainability: exploring its significance at Angelini Pharma

WHY TO PURSUE IT
Sustainability has been a frequently mentioned concept over the last few years across many manufacturing platforms but more recently has become a popular topic within the pharmaceutical industry.
One main reason for this are the advances and impact that analytical science has had in identifying pharmaceuticals as environmental contaminants that is due to their wide use. That is, pharmaceuticals and their residues/metabolites may enter surface waters via wastewater treatment plants (WWTPs) after human use (domestic and hospitals) or enter soils if sewage sludge produced during wastewater treatment is applied to agricultural land and of course emissions from API production processes may include active pharmaceutical ingredients, but also potentially harmful solvents, or byproducts of the production process.

WHAT ANGELINI PHARMA IS DOING
As a follow up to our publication in this same journal last fall focusing on “green chemistry” and its impact on production costs, here we will focus on the topic of sustainability and specifically its impact on effluent reduction and what Angelini Pharma is doing in this regard.